Nov 10 (Reuters) - Teva Pharmaceutical Industries (N:TEVA) Ltd TEVA.TA :
* Canada announces the launch of Prteva-Moxifloxacin tablet, a generic of
Pravelox
* Canada limited-Health Canada approved application for generic version of Avelox for the treatment of adults with respiratory tract infections
* Source text for Eikon ID:nCNWjft3Qa
* Further company coverage TEVA.TA